Skip to main content
. 2020 Aug 29;24(1):22–31. doi: 10.1093/ijnp/pyaa068

Figure 3.

Figure 3.

Montgomery-Asberg Depression Rating Scale (MADRS) remission rate over time during the double-blind treatment phase. aIncludes patients who had their dose reduced due to tolerability issues. Note: Remission was based on a MADRS total score of ≤12. Patients who did not meet such criterion or discontinued prior to the time point for any reason were not be considered to be in remission.